165 related articles for article (PubMed ID: 9126676)
21. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction. Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group.
Lewis BS; Poole-Wilson PA
Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():407-18. PubMed ID: 7947383
[TBL] [Abstract][Full Text] [Related]
22. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Chen YH; Liu RC; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
24. Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.
Glasser SP
Am J Cardiol; 1995 Apr; 75(13):68E-70E. PubMed ID: 7726128
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of nisoldipine coat core.
Zannad F
Am J Cardiol; 1995 Apr; 75(13):41E-45E. PubMed ID: 7726124
[TBL] [Abstract][Full Text] [Related]
26. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
Haitas B; Meyer TE; Angel ME; Reef E
Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
[TBL] [Abstract][Full Text] [Related]
27. Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group.
Eur Heart J; 1997 Jan; 18(1):31-40. PubMed ID: 9049513
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form.
Schaefer HG; Heinig R; Ahr G; Adelmann H; Tetzloff W; Kuhlmann J
Eur J Clin Pharmacol; 1997; 51(6):473-80. PubMed ID: 9112062
[TBL] [Abstract][Full Text] [Related]
29. Clinical pharmacokinetics of nisoldipine coat-core.
Heinig R
Clin Pharmacokinet; 1998 Sep; 35(3):191-208. PubMed ID: 9784933
[TBL] [Abstract][Full Text] [Related]
30. A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.
Murray TS
Br J Clin Pract; 1996; 50(7):368-72. PubMed ID: 9015908
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
Estacio RO; Schrier RW
Am J Cardiol; 1998 Nov; 82(9B):9R-14R. PubMed ID: 9822137
[TBL] [Abstract][Full Text] [Related]
32. Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Doppler Flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy.
Eur Heart J; 1992 Nov; 13(11):1496-505. PubMed ID: 1464339
[TBL] [Abstract][Full Text] [Related]
33. Calcium channel blockers and hypertension: evolving perspective--1996.
Epstein M
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():883-91. PubMed ID: 9126678
[TBL] [Abstract][Full Text] [Related]
34. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients.
Minami J; Ishimitsu T; Higashi T; Numabe A; Matsuoka H
Hypertens Res; 1998 Sep; 21(3):215-9. PubMed ID: 9786607
[TBL] [Abstract][Full Text] [Related]
35. Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED; Keating GM; Keam SJ
Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
[TBL] [Abstract][Full Text] [Related]
36. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
[TBL] [Abstract][Full Text] [Related]
37. Comparative efficacy and tolerability of nisoldipine coat core and hydrochlorothiazide in mild-to-moderate hypertension.
Fodor JG
Int J Clin Pract; 1997; 51(5):271-5. PubMed ID: 9489083
[TBL] [Abstract][Full Text] [Related]
38. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
Ehring T; Heusch G
Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
[TBL] [Abstract][Full Text] [Related]
39. A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension.
Hoglund C; Hutchinson HG
Int J Clin Pract; 1998 Jun; 52(4):221-5. PubMed ID: 9744143
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive treatment and CHD in the elderly.
Fink KS; Ellsworth A
Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
